Medscape (3/21, Davenport) reports, “Psychiatry is facing an ongoing crisis because pharmaceutical companies are not investing in” research into new psychiatric medications, “warned an investigator who has turned to nonpsychiatric” medicines “in a bid to find optimally effective treatments for his patients with mental illness.” At the European Psychiatric Association’s 24th Congress, Dominik Wincewicz, MD, of Poland’s Medical University of Bialystok suggested that “researchers…look beyond psychiatry into other specialties, such as cardiology, where already approved drugs have shown benefits in managing stress and cognitive impairment.”
Related Links:
— Medscape (requires login and subscription)